537 related articles for article (PubMed ID: 11161851)
1. Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in node-negative endometrial cancer.
Yabushita H; Shimazu M; Yamada H; Sawaguchi K; Noguchi M; Nakanishi M; Kawai M
Gynecol Oncol; 2001 Feb; 80(2):139-44. PubMed ID: 11161851
[TBL] [Abstract][Full Text] [Related]
2. [Study on cytokeratin and CA125 for diagnosing lymph node micrometastases in endometrial cancer].
Liu FH; Wang YF; Wang J; Xue Q; Jiang S; Ma YY
Zhonghua Fu Chan Ke Za Zhi; 2004 Sep; 39(9):612-5. PubMed ID: 15498190
[TBL] [Abstract][Full Text] [Related]
3. Relationship of nonstaging pathological risk factors to lymph node metastasis and recurrence in clinical stage I endometrial carcinoma.
Bell JG; Minnick A; Reid GC; Judis J; Brownell M
Gynecol Oncol; 1997 Sep; 66(3):388-92. PubMed ID: 9299250
[TBL] [Abstract][Full Text] [Related]
4. Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma: A preliminary study.
Dowlatshahi K; Fan M; Bloom KJ; Spitz DJ; Patel S; Snider HC
Cancer; 1999 Sep; 86(6):990-6. PubMed ID: 10491525
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of progesterone receptor immunohistochemistry for lymph node metastases in endometrial carcinoma.
Iwai K; Fukuda K; Hachisuga T; Mori M; Uchiyama M; Iwasaka T; Sugimori H
Gynecol Oncol; 1999 Mar; 72(3):351-9. PubMed ID: 10053107
[TBL] [Abstract][Full Text] [Related]
6. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
[TBL] [Abstract][Full Text] [Related]
7. Molecular detection of neoplastic cells in lymph nodes of metastatic colorectal cancer patients predicts recurrence.
Sanchez-Cespedes M; Esteller M; Hibi K; Cope FO; Westra WH; Piantadosi S; Herman JG; Jen J; Sidransky D
Clin Cancer Res; 1999 Sep; 5(9):2450-4. PubMed ID: 10499618
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for occult lymph node metastasis of colorectal cancer invading the submucosa and indications for endoscopic mucosal resection.
Yasuda K; Inomata M; Shiromizu A; Shiraishi N; Higashi H; Kitano S
Dis Colon Rectum; 2007 Sep; 50(9):1370-6. PubMed ID: 17661146
[TBL] [Abstract][Full Text] [Related]
9. Occult lymph node metastases in early stage vulvar carcinoma patients.
Knopp S; Holm R; Tropé C; Nesland JM
Gynecol Oncol; 2005 Nov; 99(2):383-7. PubMed ID: 16051338
[TBL] [Abstract][Full Text] [Related]
10. Significance of pathologic patterns of pelvic lymph node metastases in endometrial cancer.
Mariani A; Webb MJ; Rao SK; Lesnick TG; Podratz KC
Gynecol Oncol; 2001 Feb; 80(2):113-20. PubMed ID: 11161847
[TBL] [Abstract][Full Text] [Related]
11. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT
Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063
[TBL] [Abstract][Full Text] [Related]
12. Analysis of FIGO Stage IIIc endometrial cancer patients.
McMeekin DS; Lashbrook D; Gold M; Johnson G; Walker JL; Mannel R
Gynecol Oncol; 2001 May; 81(2):273-8. PubMed ID: 11330962
[TBL] [Abstract][Full Text] [Related]
13. Recurrence in early gastric cancer--presence of micrometastasis in lymph node of node negative early gastric cancer patient with recurrence.
Saito H; Osaki T; Murakami D; Sakamoto T; Kanaji S; Ohro S; Tatebe S; Tsujitani S; Ikeguchi M
Hepatogastroenterology; 2007 Mar; 54(74):620-4. PubMed ID: 17523336
[TBL] [Abstract][Full Text] [Related]
14. Identification of micrometastases in histologically negative lymph nodes of early-stage cervical cancer patients.
Lentz SE; Muderspach LI; Felix JC; Ye W; Groshen S; Amezcua CA
Obstet Gynecol; 2004 Jun; 103(6):1204-10. PubMed ID: 15172853
[TBL] [Abstract][Full Text] [Related]
15. Frozen section analyses as predictors of lymphatic spread in patients with early-stage uterine cancer.
Frumovitz M; Slomovitz BM; Singh DK; Broaddus RR; Abrams J; Sun CC; Bevers M; Bodurka DC
J Am Coll Surg; 2004 Sep; 199(3):388-93. PubMed ID: 15325608
[TBL] [Abstract][Full Text] [Related]
16. Detection of pelvic lymph node micrometastasis in stage IA2-IB2 cervical cancer by immunohistochemical analysis.
Juretzka MM; Jensen KC; Longacre TA; Teng NN; Husain A
Gynecol Oncol; 2004 Apr; 93(1):107-11. PubMed ID: 15047221
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
[TBL] [Abstract][Full Text] [Related]
18. Clinical value of immunohistochemically detected lymphovascular invasion in endometrioid endometrial cancer.
Alexander-Sefre F; Singh N; Ayhan A; Thomas JM; Jacobs IJ
Gynecol Oncol; 2004 Feb; 92(2):653-9. PubMed ID: 14766262
[TBL] [Abstract][Full Text] [Related]
19. Percent surface area involvement is a predictor of lymph node metastasis in endometrial cancer.
Axtell AE; Kelley JL; Fader AN; Gupta D; Schwartz B; Comerci JT; Lin Y; Weiand S; Gallion HH; Kanbour-Shakir A
Gynecol Oncol; 2007 Dec; 107(3):482-6. PubMed ID: 17850853
[TBL] [Abstract][Full Text] [Related]
20. Myometrial invasion and lymph node metastasis in endometrioid carcinomas: tumor-associated macrophages, microvessel density, and HIF1A have a crucial role.
Espinosa I; José Carnicer M; Catasus L; Canet B; D'angelo E; Zannoni GF; Prat J
Am J Surg Pathol; 2010 Nov; 34(11):1708-14. PubMed ID: 20962622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
